Proposed Changes to Scientific Research Grants Under Trump Administration

Proposed Changes to Federal Research Grants Under Trump Administration

The Trump administration is contemplating a significant shift in the management of federal research grants, which could introduce greater political influence into the funding process. This potential change is especially relevant for the health and science funding sectors, where the implications are expected to be pronounced.

In an editorial, Holden Thorp, editor of Science magazine, expressed concern over the proposal, stating, “Although research has bipartisan support in the US Congress, and trust in science is above 75% across the country, the Trump administration seems as determined as ever to mortally wound the nation’s scientific enterprise.” His commentary highlights the potential risks associated with the proposed changes.

Details of the changes, first published in the Federal Register on May 29, could formalize mechanisms that critics argue may undermine specific research disciplines in the United States. The adjustment seeks to allow greater authority for promoting the priorities of the presidency, thereby affecting diverse fields such as public health, vaccine research, biotechnology, social sciences, and climate science.

This proposed rule has prompted reactions from various advocacy and scientific organizations. Cole Donovan from Stand Up for Science has been vocal about the potential consequences, stating, “This would be the end of American science as we know it. We’re gonna make sure that it doesn’t fade quietly into the night.”

Concerns About Peer Review Integrity

Since the mid-20th century, peer review has played a vital role in preserving the integrity of research and guiding federal funding allocations. Historically, federal agencies have relied on independent advisory committees to make informed decisions on a range of matters, from vaccination guidelines to environmental regulations.

Even though peer review has never been legally binding, it has remained an essential norm within government. Donovan pointed out, “While it’s been true that peer review panels have always been treated as advisory by agencies, it was usually the combination of peer review with a non-political career expert at an agency that made the determination of whether to issue an award or not.”

The proposed rule would not eliminate peer review but would introduce a requirement that political appointees, who may not have scientific expertise, evaluate grants prior to final decisions being made. This change raises concerns about granting these appointees potential veto power over projects that have already been approved through peer review processes.

Historians and members of the scientific community have expressed unease regarding what these alterations could mean for the future of research funding. Historian Tim Snyder remarked that the proposal resembles “late Stalinism,” warning against the possibility of non-experts making influential decisions. The Infectious Diseases Society of America emphasized their concerns in a statement, asserting that the rule “would replace scientific merit with McCarthy era politics.”

The shift in policy was initiated by the White House Office of Management and Budget, which is led by Director Russell Vought. An OMB spokesperson claimed that the changes are intended to improve efficiency, stating that it will “improve the ability of agencies to identify and respond to waste, fraud, and abuse.” In contrast, critics argue there is no substantiated evidence that existing peer-review protocols are plagued by issues of this nature.

Elizabeth Ginexi, a former official at the National Institutes of Health, questioned the rationale behind allowing individuals without scientific training to engage in scientific decision-making, asking, “When we’re designing a study to a new cancer therapeutic, do you want Russell Vought — who is not a scientist — to determine which immunotherapy is ready to go into a phase three trial?”

The proposed rule would also impose restrictions on research related to diversity, equity, and inclusion and prohibit conditions related to gender in grant applications, alongside limiting international scientific collaboration. Donovan noted the significance of global cooperation in producing impactful research.

Limited Congressional Response

Congressman James Walkinshaw, a Democrat from Virginia, has raised alarms about the potential for political ideology to dictate research funding, stating, “The question isn’t whether politics will influence research under this proposal. That’s the point.”

While there are appeals for public engagement on this matter, direct intervention from Congress appears unlikely. The proposal remains open for public comment until July 13, after which feedback will be reviewed by the OMB to determine the next steps regarding the rule. Donovan has suggested that if the rule is implemented, it will likely face legal challenges.